DNA synthesis is becoming an increasingly important technology in modern biotechnology. It enables researchers to create customized DNA sequences for gene cloning, genome editing, synthetic biology, diagnostics, drug development, and advanced therapies.
The global DNA synthesis sector was valued at USD 5.42 billion in 2025 and is estimated to reach USD 6.37 billion in 2026. It is projected to reach approximately USD 27.03 billion by 2035, expanding at a 17.42% CAGR from 2026 to 2035.
What Is Driving Growth?
One of the strongest factors behind this expansion is the growing use of synthetic DNA in gene therapies, CRISPR-based genome editing, vaccines, molecular diagnostics, and personalized medicine. As researchers increasingly work with customized genetic sequences, demand for accurate, scalable, and reliable DNA synthesis solutions continues to increase.
Collaboration among biotechnology companies is also accelerating innovation. In March 2025, Elegen partnered with Integrated DNA Technologies (IDT) to provide early access to Elegen’s ENFINIA plasmid DNA service. In the same month, Syngoi Technologies and Ribbon Bio announced a strategic partnership focused on producing synthetic DNA at gram scale.
Technology Innovation
Traditional solid-phase DNA synthesis continues to play an important role and accounted for approximately 48% of the technology segment in 2025. However, enzymatic DNA synthesis is gaining attention because it can use milder conditions and potentially reduce chemical waste.
Artificial intelligence is also changing how researchers design and analyze genetic sequences. AI can process large genomic datasets, identify patterns, predict the effects of genetic changes, and support faster experimentation. This combination of AI and DNA synthesis could make genetic research more efficient and precise.
Key Application Areas
Research and development represented the largest application segment, accounting for approximately 44% in 2025. Academic institutions, biotechnology companies, and pharmaceutical organizations rely heavily on synthetic DNA for genetic research and experimental development.
Therapeutics development is expected to expand rapidly as gene therapies and other advanced biological treatments continue to progress. Synthetic DNA is essential for developing genetic constructs and supporting new therapeutic approaches.
Regional Outlook
North America led the sector in 2025, supported by strong research infrastructure, biotechnology companies, investment, and advanced genomics capabilities.
Asia Pacific is expected to experience the fastest growth. China and India are strengthening their biotechnology ecosystems, while government support, research investment, precision medicine, and synthetic biology are creating additional opportunities.
Europe is also advancing through strong research capabilities, biotechnology development, and growing interest in genomics and personalized healthcare.
Download a Sample Report: https://www.towardshealthcare.com/download-sample/6162
Looking Ahead
The future of DNA synthesis will be shaped by automation, enzymatic technologies, AI-driven design, synthetic biology, and gene-based therapies. As synthesis becomes faster, more scalable, and potentially more sustainable, it could enable researchers to develop new therapies, biological products, and genetic technologies more efficiently.
With a projected value of USD 27.03 billion by 2035, DNA synthesis is positioned to become an increasingly important foundation for the next generation of biotechnology and precision healthcare.
About Us
Healthcare WebWire is a part of Towards Healthcare Research & Consulting which is a global healthcare market research and consulting firm dedicated to helping businesses make informed decisions through reliable market intelligence and strategic insights. We serve pharmaceutical, biotechnology, medical device, AI in healthcare, cell and gene therapy, digital health, and life sciences organizations with in-depth market research, custom consulting, competitive analysis, and growth forecasts. Our team combines industry expertise with rigorous research to deliver clear, actionable insights that support market expansion, product strategy, investment decisions, and long-term business growth. From emerging innovations to established healthcare markets, we help organizations understand where the industry is today and where it’s headed tomorrow.
You can place an order or ask any questions, please feel free to contact us at [email protected]
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
APAC Region: +91 9356 9282 04
Visit Our Website: Towards Healthcare Research & Consulting – Expert Consulting Solutions & Research Reports
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium